2022
DOI: 10.1016/j.hfc.2022.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Cardioprotection of High-Risk Individuals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 138 publications
0
1
0
Order By: Relevance
“…The primary prevention approach can be contemplated for HF, ischemia, arrhythmia, hypertension, and thromboembolism. However, most of the literature and recommendations available are focused on prevention of HF in patients treated with anthracyclines; therefore, specific strategies on the primary prevention for specific CV side effects represents a gap in the evidence in need of further research [ 22 , 27 ].…”
Section: A Stepwise Approach For Prevention And/or Early Detection Of...mentioning
confidence: 99%
“…The primary prevention approach can be contemplated for HF, ischemia, arrhythmia, hypertension, and thromboembolism. However, most of the literature and recommendations available are focused on prevention of HF in patients treated with anthracyclines; therefore, specific strategies on the primary prevention for specific CV side effects represents a gap in the evidence in need of further research [ 22 , 27 ].…”
Section: A Stepwise Approach For Prevention And/or Early Detection Of...mentioning
confidence: 99%